Medical Device Nonvisual Accessibility Act of 2024

The Medical Device Nonvisual Accessibility Act of 2024 requires manufacturers of certain home-use medical devices - such as blood pressure monitors, sleep apnea machines, and in-home chemotherapy equipment - to design user interfaces that are accessible to blind or low-vision individuals. This applies to class II or III devices with screens or mobile apps that are cleared for home use, not solely for healthcare providers. The law mandates that interfaces must provide equal privacy, independence, and ease of use for blind or low-vision users as for sighted users, with manufacturers able to request waivers for "fundamental alteration" or "undue hardship" (e.g., excessive cost). The Secretary of Health and Human Services must develop implementing regulations within two years and provide manufacturer training.